Side-by-side financials for COCP and JNJ. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COCP | JNJ |
|---|---|---|
| Market cap | - | $574.10 B |
| US-listed rank | - | #20 |
| Revenue (latest FY) | $2.01M | $94.19B |
| Net income (latest FY) | -$8.83M | $26.80B |
| Net margin | -438.5% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 655 | 984 |
Full pages: Cocrystal Pharma, Inc. and JOHNSON & JOHNSON, or browse the full rankings.